- Ticker
- ABCL
- Price
- 7.31
- Stock movement up
- +0.40 (5.79%)
- Company name
- Abcellera Biologics Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 2.10B
- Ent value
- 2.02B
- Price/Sales
- 4.33
- Price/Book
- 1.71
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- 13.27
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -4.69%
- 3 year return
- -
- 5 year return
- -
- 10 year return
- -
Last updated: 2023-06-07
Get the latest news and real-time alerts from AbCellera Biologics Inc. (ABCL) stock at Seeking Alpha.
May 24, 2023
iO Charts is a Seeking Alpha partner
AbCellera reported Q1 2023 results on May 4th. While it appears to have no clear catalyst to rise in the short term, see why I rate ABCL stock a Buy.
May 6, 2023
iO Charts is a Seeking Alpha partner
DIVIDENDS
ABCL does not pay dividends or no data was received
Loading...
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | 13.27 |
| Price to OCF | 7.58 |
| Price to FCF | 10.27 |
| Price to EBITDA | 7.73 |
| EV to EBITDA | 7.44 |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 4.33 |
| Price to Book | 1.71 |
| EV to Sales | 4.17 |
AbCellera Biologics Inc. (NASDAQ:NASDAQ:ABCL) Q1 2023 Results Conference Call May 4, 2023 5:00 PM ETCompany ParticipantsTryn Stimart - Chief Legal and Compliance OfficerDr.
May 5, 2023
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from AbCellera Biologics Inc. (ABCL) stock at Seeking Alpha.
May 4, 2023
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 287.69M |
| EPS (TTM) | 0.50 |
| FCF per share (TTM) | 0.65 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 485.43M |
| Gross profit (TTM) | 418.99M |
| Operating income (TTM) | 218.19M |
| Net income (TTM) | 158.52M |
| EPS (TTM) | 0.50 |
| EPS (1y forward) | -0.65 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 86.31% |
| Operating margin (TTM) | 44.95% |
| Profit margin (TTM) | 32.66% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 386.54M |
| Net receivables | 103.41M |
| Total current assets | 1.03B |
| Goodwill | 47.81M |
| Intangible assets | 131.50M |
| Property, plant and equipment | 0.00 |
| Total assets | 1.54B |
| Accounts payable | 14.83M |
| Short/Current long term debt | 82.26M |
| Total current liabilities | 118.32M |
| Total liabilities | 307.63M |
| Shareholder's equity | 1.23B |
| Net tangible assets | 1.05B |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | 277.36M |
| Capital expenditures (TTM) | 72.66M |
| Free cash flow (TTM) | 204.70M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | 12.85% |
| Return on Assets | 10.29% |
| Return on Invested Capital | 12.80% |
| Cash Return on Invested Capital | 16.52% |
Loading...
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 6.97 |
| Daily high | 7.40 |
| Daily low | 6.94 |
| Daily Volume | 4.58M |
| All-time high | 53.20 |
| 1y analyst estimate | 28.33 |
| Beta | -0.09 |
| EPS (TTM) | 0.50 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | 7 Aug 2023 |
Downside potential
Loading...
Downside potential data
| ABCL | S&P500 | |
| Current price drop from All-time high | -86.26% | -10.71% |
| Highest price drop | -89.36% | -56.47% |
| Date of highest drop | 9 May 2023 | 9 Mar 2009 |
| Avg drop from high | -68.83% | -11.53% |
| Avg time to new high | 125 days | 13 days |
| Max time to new high | 592 days | 1805 days |
Get the latest news and real-time alerts from AbCellera Biologics Inc. (ABCL) stock at Seeking Alpha.
May 3, 2023
iO Charts is a Seeking Alpha partner
AbCellera is pledging to discover promising antibodies for its clients and bring them to the clinic faster than anybody else. Read more about ABCL and the challenges it faces.
March 24, 2023
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
2.10B
Marketcap category
Mid-cap
Description
AbCellera Biologics Inc. builds an engine for antibody drug discovery and development. Its engine discovers antibodies from natural immune responses, which are pre-enriched for antibodies. The company had discovery programs that are either completed, in progress, or under contract with partners. It has a research collaboration and license agreement with Eli Lilly and Company. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.
Employees
495
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
Today, we take a deeper look at AbCellera Biologics whose Covid revenue stream is fading fast as the pandemic ends. Click here to see our take on ABCL stock.
March 23, 2023
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from AbCellera Biologics Inc. (ABCL) stock at Seeking Alpha.
March 22, 2023
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
The following slide deck was published by AbCellera Biologics Inc.
February 22, 2023
AbCellera Biologics Inc. (NASDAQ:NASDAQ:ABCL) Q4 2022 Earnings Conference Call February 21, 2023 5:00 PM ETCompany ParticipantsTryn Stimart - Chief Legal and Compliance OfficerCarl Hansen -...
February 22, 2023
Get the latest news and real-time alerts from AbCellera Biologics Inc. (ABCL) stock at Seeking Alpha.
February 21, 2023
Get the latest news and real-time alerts from AbCellera Biologics Inc. (ABCL) stock at Seeking Alpha.
February 20, 2023
In this article, I will provide my valuation model for AbCellera, building on an article I wrote over a year ago. See why I'm fervently bullish on ABCL stock.
January 5, 2023
Get the latest news and real-time alerts from AbCellera Biologics Inc. (ABCL) stock at Seeking Alpha.
December 15, 2022
Get the latest news and real-time alerts from AbCellera Biologics Inc. (ABCL) stock at Seeking Alpha.
December 1, 2022
Get the latest news and real-time alerts from AbCellera Biologics Inc. (ABCL) stock at Seeking Alpha.
November 30, 2022
Get the latest news and real-time alerts from AbCellera Biologics Inc. (ABCL) stock at Seeking Alpha.
November 16, 2022
AbCellera Biologics has multiple high-value opportunities that should become clear in the next few years. Find out why I'm confident in the long-term return potential of ABCL.
November 9, 2022
iO Charts is a Seeking Alpha partnerNext page